Jade Biosciences, Inc.
JBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001798749
No open-market purchases or sales by Jade Biosciences, Inc. insiders were filed in the last 90 days; 153 institutions reported holding it in 13F filings for Q2 2026, worth $1.62B in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Jade Biosciences, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 64
- +7 vs. Q3 2023
- Shares held
- 28.2M
- +323.5K (+1.2%) vs. Q3 2023
- Total value
- $637.8M
- +$259.7M (+68.7%) vs. Q3 2023
- New holders
- 11
- 21 more added
- Sold out
- 4
- 17 more reduced
1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting JBIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 153 | $1.62B |
| Q1 2026 | 120 | $700.3M |
| Q4 2025 | 105 | $726.3M |
| Q3 2025 | 78 | $272.9M |
| Q2 2025 | 75 | $315.1M |
| Q1 2025 | 82 | $79.6M |
| Q4 2024 | 80 | $79.9M |
| Q3 2024 | 75 | $57.8M |
| Q2 2024 | 81 | $45.1M |
| Q1 2024 | 81 | $841.5M |
| Q4 2023 | 64 | $637.8M |
| Q3 2023 | 58 | $386.3M |
| Q2 2023 | 60 | $488.3M |
| Q1 2023 | 66 | $524.1M |
| Q4 2022 | 70 | $802.9M |
| Q3 2022 | 56 | $447.4M |
| Q2 2022 | 51 | $403.0M |
| Q1 2022 | 46 | $475.5M |
| Q4 2021 | 47 | $301.6M |
| Q3 2021 | 41 | $452.6M |
| Q2 2021 | 18 | $454.4M |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Jade Biosciences, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| GAMMA Investing LLC | 80 | $1.54K | 0.00% | +80 | New |
| Fortitude Family Office, LLC | 416 | $9.41K | 0.01% | +416 | New |
| Metropolitan Life Insurance Co | 701 | $15.9K | 0.00% | 00.0% | Unchanged |
| Ameritas Investment Partners, Inc. | 772 | $17.5K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 922 | $20.9K | 0.00% | −518−36.0% | Reduced |
| Amalgamated Bank | 1,432 | $32.0K | 0.00% | −103−6.7% | Reduced |
| Legal & General Group Plc | 1,666 | $37.7K | 0.00% | −6,026−78.3% | Reduced |
| California State Teachers Retirement System | 1,840 | $41.6K | 0.00% | −9,172−83.3% | Reduced |
| Citigroup Inc | 2,095 | $47.4K | 0.00% | +1,882+883.6% | Added |
| STRS Ohio | 2,300 | $52.0K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 2,914 | $65.9K | 0.00% | +660+29.3% | Added |
| Royal Bank of Canada | 3,475 | $79.0K | 0.00% | +2,075+148.2% | Added |
| New York State Common Retirement Fund | 4,303 | $97.4K | 0.00% | −15−0.3% | Reduced |
| Deutsche Bank AG | 4,985 | $112.8K | 0.00% | 00.0% | Unchanged |
| MetLife Investment Management | 5,228 | $118.3K | 0.00% | 00.0% | Unchanged |
| American International Group, Inc. | 5,556 | $125.7K | 0.00% | −23−0.4% | Reduced |
| EntryPoint Capital, LLC | 6,133 | $138.8K | 0.13% | +6,133 | New |
| JPMorgan Chase & Co | 7,476 | $169.2K | 0.00% | +57+0.8% | Added |
| HRT Financial LP | 9,433 | $213.0K | 0.00% | +9,433 | New |
| Two Sigma Investments, LP | 9,760 | $220.9K | 0.00% | −2,044−17.3% | Reduced |
| Golden State Equity Partners | 10,880 | $246.2K | 0.06% | +350+3.3% | Added |
| Eventide Asset Management, LLC | 12,178 | $275.6K | 0.00% | +12,178 | New |
| UBS Group AG | 12,241 | $277.0K | 0.00% | +1,027+9.2% | Added |
| Alliancebernstein L.P. | 13,100 | $296.5K | 0.00% | +650+5.2% | Added |
| Jane Street Group, LLC | 13,106 | $296.6K | 0.00% | +13,106 | New |
| Takeda Pharmaceutical Co Ltd | 13,580 | $307.3K | 0.09% | +13,580 | New |
| Rhumbline Advisers | 14,157 | $320.4K | 0.00% | +164+1.2% | Added |
| Dimensional Fund Advisors LP | 14,957 | $338.9K | 0.00% | −5,589−27.2% | Reduced |
| Barclays PLC | 15,394 | $348.4K | 0.00% | +11,548+300.3% | Added |
| Parkwood LLC | 15,786 | $357.0K | 0.06% | −4,867−23.6% | Reduced |
| Alps Advisors Inc | 18,718 | $423.6K | 0.00% | −1,677−8.2% | Reduced |
| Bank of America Corp | 22,698 | $513.7K | 0.00% | +12,393+120.3% | Added |
| Charles Schwab Investment Management Inc | 29,542 | $668.5K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 35,052 | $793.2K | 0.00% | +15,999+84.0% | Added |
| Fred Alger Management, LLC | 36,478 | $825.5K | 0.00% | +11,731+47.4% | Added |
| Bank of New York Mellon Corp | 36,558 | $827.3K | 0.00% | +9,146+33.4% | Added |
| Nuveen Asset Management, LLC | 40,047 | $906.3K | 0.00% | +3,737+10.3% | Added |
| Nan Fung Group Holdings Ltd | 47,936 | $1.08M | 0.68% | 00.0% | Unchanged |
| Eversept Partners, LP | 50,242 | $1.14M | 0.11% | 00.0% | Unchanged |
| Skandinaviska Enskilda Banken AB (publ) | 50,866 | $1.15M | 0.01% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 91,188 | $2.06M | 0.21% | −3,812−4.0% | Reduced |
| Northern Trust Corp | 99,527 | $2.25M | 0.00% | −10,916−9.9% | Reduced |
| Hudson Bay Capital Management LP | 103,000 | $2.33M | 0.02% | +103,000 | New |
| Ensign Peak Advisors, Inc | 122,257 | $2.77M | 0.01% | +107,257+715.0% | Added |
| Paradigm Biocapital Advisors LP | 143,235 | $3.24M | 0.15% | +143,235 | New |
| Ghost Tree Capital, LLC | 210,000 | $4.75M | 2.74% | +8,803+4.4% | Added |
| State Street Corp | 214,027 | $4.84M | 0.00% | +32,523+17.9% | Added |
| Geode Capital Management, LLC | 276,895 | $6.27M | 0.00% | +27,087+10.8% | Added |
| Vestal Point Capital, LP | 400,000 | $9.05M | 0.96% | +400,000 | New |
| Octagon Capital Advisors LP | 403,685 | $9.14M | 1.46% | −93,685−18.8% | Reduced |
| Point72 Asset Management, L.P. | 441,474 | $9.99M | 0.03% | +441,474 | New |
| FMR LLC | 537,486 | $12.2M | 0.00% | +7,942+1.5% | Added |
| Vanguard Group Inc | 626,831 | $14.2M | 0.00% | +27,729+4.6% | Added |
| BlackRock Inc. | 727,454 | $16.5M | 0.00% | +44,673+6.5% | Added |
| OrbiMed Advisors LLC | 756,930 | $17.1M | 0.34% | 00.0% | Unchanged |
| Great Point Partners LLC | 1,037,690 | $23.5M | 4.00% | −53,543−4.9% | Reduced |
| Driehaus Capital Management LLC | 1,058,209 | $23.9M | 0.29% | −129,409−10.9% | Reduced |
| Frazier Life Sciences Management, L.P. | 1,204,867 | $27.3M | 1.46% | 00.0% | Unchanged |
| Cormorant Asset Management, LP | 1,211,696 | $27.4M | 1.31% | −350,000−22.4% | Reduced |
| Baker Bros. Advisors LP | 1,680,517 | $38.0M | 0.43% | −282,962−14.4% | Reduced |
| Atlas Venture Life Science Advisors, LLC | 2,039,249 | $46.1M | 5.50% | 00.0% | Unchanged |
| TCG Crossover Management, LLC | 2,201,274 | $49.8M | 5.52% | 00.0% | Unchanged |
| Sofinnova Investments, Inc. | 3,758,686 | $85.1M | 4.76% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 8,263,982 | $187.0M | 2.92% | 00.0% | Unchanged |
| Silverarc Capital Management, LLC | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −53,365−100.0% | Sold out |
| Swiss National Bank | 0 | $0 | 0.00% | −21,201−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −17,644−100.0% | Sold out |
| OUP Management Co., LLC | – | – | – | – | Not filed |